CC
FRTX

Clearline Capital’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Clearline Capital’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-239
Closed -$90K – 57
2019
Q1 		$90K Buy
239
+1
+0.4% +$377 0.05% 39
2018
Q4 		$89K Buy
238
+69
+41% +$25.8K 0.06% 59
2018
Q3 		$73K Buy
+169
New +$73K 0.04% 50